ONYX-015 selectivity and the p14ARF pathway

Area of Science:

• Oncolytic virology
• Molecular oncology
• Gene therapy

Background:

• ONYX-015 (dl1520) is an adenovirus engineered to lack the E1B 55K gene.
• This genetic modification impairs its ability to neutralize the p53 tumor suppressor protein.
• Adenoviruses typically hijack cellular machinery; ONYX-015's modification alters its interaction with host cell pathways.

Purpose of the Study:

• To investigate the replication mechanism of ONYX-015 in different cell types.
• To elucidate the role of p53 and its regulatory proteins in ONYX-015 replication.
• To understand why ONYX-015 replicates in tumor cells but not primary epithelial cells.

Main Methods:

• Infection of primary epithelial cells and tumor cells with ONYX-015.
• Analysis of p53 protein levels and activity post-infection.
• Investigation of the p14ARF and Mdm2 pathways in infected cells.
• Assessment of viral replication efficiency in various cell lines.

Main Results:

• ONYX-015 replicates inefficiently in primary epithelial cells, inducing high p53 levels.
• Replication is efficient in many tumor cells, even those with wild-type p53.
• In tumor cells, ONYX-015 fails to induce active p53 due to a disrupted E1A-p53 pathway linked to p14ARF loss.
• Elevated Mdm2 activity (from p14ARF loss or activated Ras) prevents functional p53 accumulation during infection.

Conclusions:

• The E1B 55K deletion in ONYX-015 leads to differential replication based on host cell p53 pathway status.
• Loss of p14ARF and subsequent Mdm2 hyperactivity are key mechanisms allowing ONYX-015 to evade p53-mediated suppression in tumor cells.
• These findings highlight the importance of the p53 pathway in determining the efficacy of oncolytic adenoviruses like ONYX-015.